© 1995 American Heart Association, Inc.
Articles |
Dominant Social Status and Contraceptive Hormone Treatment Inhibit Atherogenesis in Premenopausal Monkeys
From the Comparative Medicine Clinical Research Center (J.R.K., M.R.A., M.S.A., T.B.C.) and the Department of Public Health Sciences (T.M.M.), Bowman Gray School of Medicine of Wake Forest University, Winston-Salem, NC, and the Behavioral Physiology Laboratory, University of Pittsburgh, Pa (S.B.M.).
Abstract The stress of social subordination is associated with exacerbation of coronary artery atherosclerosis in premenopausal cynomolgus monkeys, possibly as a result of the ovarian dysfunction that reliably accompanies subordinate social status. The primary objective of the current study was to determine whether treatment with an oral contraceptive (OC) provides relative protection from development of atherosclerotic plaques, especially among animals made vulnerable to atherosclerosis by social subordination. In the present study, 193 adult female monkeys (Macaca fascicularis) were placed in social groups of 5 or 6 animals each. Half of the animals were then fed an atherogenic diet to which had been added a triphasic OC, while the remainder received only the atherogenic diet. At the end of 26 months, atherosclerosis was measured in an iliac artery biopsy taken from each monkey. The results demonstrated that among untreated animals subordinate individuals developed significantly more atherosclerosis than did their dominant counterparts (P<.01); however, OC treatment inhibited atherosclerosis in subordinate animals (P<.05) and eliminated the difference between dominant and subordinate animals that was observed in the untreated condition. Subordinate social status and OC treatment were both associated with reduced plasma concentrations of HDL cholesterol (P<.01 for both), and subordinate monkeys also had elevations in LDL cholesterol plus VLDL cholesterol (P<.01). Nonetheless, the interaction between social status and OC treatment remained significant even after covariance adjustment for variation in plasma lipids. Taken together, these results suggest that social subordination worsens, whereas OC treatment inhibits, atherosclerosis, and that these effects are independent of concomitant variability in plasma lipids.
Key Words: cynomolgus monkeys • atherosclerosis • stress • oral contraceptives • risk factors
This article has been cited by other articles:
 |
|
 |
|
  C. L. Shufelt and C. N. Bairey Merz Contraceptive hormone use and cardiovascular disease. J. Am. Coll. Cardiol., January 20, 2009; 53(3): 221 - 231. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. K. Snell-Bergeon, D. Dabelea, L. G. Ogden, J. E. Hokanson, G. L. Kinney, J. Ehrlich, and M. Rewers Reproductive History and Hormonal Birth Control Use Are Associated with Coronary Calcium Progression in Women with Type 1 Diabetes Mellitus J. Clin. Endocrinol. Metab., June 1, 2008; 93(6): 2142 - 2148. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Register, J. A. Cann, J. R. Kaplan, J. K. Williams, M. R. Adams, T. M. Morgan, M. S. Anthony, R. M. Blair, J. D. Wagner, and T. B. Clarkson Effects of Soy Isoflavones and Conjugated Equine Estrogens on Inflammatory Markers in Atherosclerotic, Ovariectomized Monkeys J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1734 - 1740. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Morimoto, Y. Kurahashi, K. Shintani-Ishida, N. Kawamura, M. Miyashita, M. Uji, N. Tan, and K.-i. Yoshida Estrogen replacement suppresses stress-induced cardiovascular responses in ovariectomized rats Am J Physiol Heart Circ Physiol, November 1, 2004; 287(5): H1950 - H1956. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. N. Kalantaridou, K. K. Naka, E. Papanikolaou, N. Kazakos, M. Kravariti, K. A. Calis, E. A. Paraskevaidis, D. A. Sideris, A. Tsatsoulis, G. P. Chrousos, et al. Impaired Endothelial Function in Young Women with Premature Ovarian Failure: Normalization with Hormone Therapy J. Clin. Endocrinol. Metab., August 1, 2004; 89(8): 3907 - 3913. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E. Wood, J. M. Cline, M. S. Anthony, T. C. Register, and J. R. Kaplan Adrenocortical Effects of Oral Estrogens and Soy Isoflavones in Female Monkeys J. Clin. Endocrinol. Metab., May 1, 2004; 89(5): 2319 - 2325. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. C. Register, M. J. Jayo, and M. S. Anthony Soy Phytoestrogens Do Not Prevent Bone Loss in Postmenopausal Monkeys J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4362 - 4370. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Alexandersen, J. Haarbo, P. Zandberg, J. Jespersen, S. O. Skouby, and C. Christiansen Lack of difference among progestins on the anti-atherogenic effect of ethinyl estradiol: a rabbit study Hum. Reprod., July 1, 2003; 18(7): 1395 - 1403. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Noel Bairey Merz, B. D. Johnson, B. L. Sharaf, V. Bittner, S. L. Berga, G. D. Braunstein, T. K. Hodgson, K. A. Matthews, C. J. Pepine, S. E. Reis, et al. Hypoestrogenemia of hypothalamic origin and coronary artery disease in premenopausal women: a report from the NHLBI-sponsored WISE study J. Am. Coll. Cardiol., February 5, 2003; 41(3): 413 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. B. Clarkson, M. S. Anthony, and T. M. Morgan Inhibition of Postmenopausal Atherosclerosis Progression: A Comparison of the Effects of Conjugated Equine Estrogens and Soy Phytoestrogens J. Clin. Endocrinol. Metab., January 1, 2001; 86(1): 41 - 47. [Abstract] [Full Text]
|
|
|
|
 |
|
 P. Holvoet, G. Theilmeier, B. Shivalkar, W. Flameng, and D. Collen LDL Hypercholesterolemia Is Associated With Accumulation of Oxidized LDL, Atherosclerotic Plaque Growth, and Compensatory Vessel Enlargement in Coronary Arteries of Miniature Pigs Arterioscler. Thromb. Vasc. Biol., March 1, 1998; 18(3): 415 - 422. [Abstract] [Full Text] [PDF]
|
|